Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 30.50
-0.50 (-1.61%)
Sep 25, 2026, 3:37 PM GMT
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 42.96 million as of September 25, 2026. Its market cap has increased by 15.25% in one year.
Market Cap
42.96M
Enterprise Value
40.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.50
ChartMarket Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 42.96M, an increase of 394.09%. That is a compound annual growth rate of 7.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 42.96M | 107.42% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 117.59M |
| 4basebio | 87.40M |
| Bioventix | 80.99M |
| Faron Pharmaceuticals Oy | 73.32M |
| Poolbeg Pharma | 69.09M |
| Ondine Biomedical | 55.85M |
| Arecor Therapeutics | 33.41M |
| Hemogenyx Pharmaceuticals | 31.96M |